Kartik Cherabuddi

Kartik Cherabuddi, MD, FACP

Associate Professor Of Medicine

Business Phone: (352) 273-5499
Business Email: cherabuddi@ufl.edu

About Kartik Cherabuddi

Dr. Kartik Cherabuddi provides clinical care to patients with complex infectious diseases; patients living with HIV; and internal medicine patients. He serves as a specialist for antibiotic resistant pathogen infections. He is the Director of Antimicrobial Stewardship Program at UFHealth. He also serves as the Associate Hospital Epidemiologist providing leadership for infection control issues.

Dr. Cherabuddi has been recognized as a Master Clinician and inducted into the Master Clinician Society at UF. He is an award winning educator recognized as an Exemplary Clinician through the college of medicine and in multiple years for excellence in teaching through the department of medicine (DOM). He enjoys teaching medical students, PA students, pharmacists, residents and ID fellows. He has been recognized as the DOM Attending of the year by the residents. He serves as the Associate Program Director for the ID Fellowship program.

Dr. Cherabuddi conducts research through clinical trials for novel antimicrobial compounds that enables transition to patient care. He also conducts research looking at Antibiotic resistance and genetic sequencing of microorganisms. He collaborates with researchers at the UF Emerging Pathogen Institute on (re)emerging viral infections including Zika, Chikungunya and Keystone viruses.

Dr. Cherabuddi also serves on international infectious diseases committees to develop enhanced training in Antibiotic Stewardship.

Board Certifications

  • Infectious Diseases
    American Board of Multiple Specialties
  • Internal Medicine
    American Board of Internal Medicine

Clinical Profile

  • Medicine
  • Infectious Disease
Areas of Interest
  • Infectious endocarditis
  • Osteomyelitis
  • Pseudomembranous colitis
  • Secondary infections
  • Surgical wound infection – treatment
  • Urinary tract infection – adults

Research Profile

Areas of Interest
  • CNS infection
  • Clostridium difficile infection
  • HIV
  • Orthopedic infection
  • Tuberculosis


2018 Infection Control and Hospital Epidemiology
2018 Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2018 Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2014 Academic Medicine : Journal of the Association of American Medical Colleges


Oct 2018 ACTIVE
CRBSI/CLABSI Infection Detection Project
ARROW INTERNATIONAL · Principal Investigator
Feb 2018 – Nov 2019
A Phase 2 Proof-of-Concept Study to Evaluate the Efficacy and Safety of MEDI3902 in Mechanically Ventilated Patients for the Prevention of Nosocomial Pneumonia Caused by Pseudomonas aeruginosa
DUKE UNIV MEDICAL CTR · Principal Investigator
Jan 2011 – Jan 2019
A Phase 2 Randomised, Double-blind, Placebo-controlled, Single-dose, Dose-ranging Study of the Efficacy and Safety of MEDI4893, a Human Monoclonal Antibody Against Staphylococcus aureus Alpha Toxin in Mechanically Ventilated Adult Subjects
DUKE UNIV MEDICAL CTR · Principal Investigator


Fellowship – Infectious Disease
2013 · University of Florida
Residency – Internal Medicine
2011 · Westlake Hospital
Residency – Internal Medicine
2010 · Westlake Hospital
Internship – Internal Medicine
2008 · Westlake Hospital
Rotating Internship
2004 · Kakatiya Medical College
Bachelor of Medicine, Bachelor of Surgery
2004 · Kakatiya Medical College

Contact Details

(352) 273-5499
PO Box 100289